• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Th1和Th2细胞因子mRNA的相对表达水平是卵巢癌患者独立的预后因素。

Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.

作者信息

Kusuda Tomoyo, Shigemasa Kazushi, Arihiro Koji, Fujii Tsuneo, Nagai Nobutaka, Ohama Koso

机构信息

Department of Obstetrics and Gynecology, Hiroshima University Graduate School of Biomedical Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan.

出版信息

Oncol Rep. 2005 Jun;13(6):1153-8.

PMID:15870936
Abstract

The aim of the present study was to examine mRNA expression levels of Th1 (TNF-alpha , IFN-gamma, and IL-12p40) and Th2 (IL-6 and IL-10) cytokines for any association with clinicopathological characteristics of epithelial ovarian cancer. mRNA was isolated, and cDNA prepared from 40 samples of epithelial ovarian cancers. Expression level of each cytokine mRNA was examined by the real-time PCR technique (GAPDH gene, internal control). Expression ratio (target gene/GAPDH) was used to evaluate gene expression. Results were analyzed against clinical stage, histological grade, and histological type. Prognostic significance of expression levels of each combination of Th1/Th2 values was assessed. Tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) expression levels were significantly higher in serous adenocarcinoma than in non-serous adenocarcinoma (p<0.05), but with no difference between individual cytokine mRNA expression levels and clinical stage or histological grade. Log-rank testing showed that high TNF-alpha mRNA expression (p=0.033) and the diameter of largest residual lesion at initial surgery (p=0.012) significantly correlate with longer survival in advanced stage (II/III/IV) ovarian carcinomas. In examining all combinations of Th1/Th2 expression values, the most significant association was between high IFN-gamma.IL-12p40/IL-6 expression levels and better prognosis in advanced stage (II/III/IV) ovarian carcinomas (p=0.004). In multivariate analysis, high IFN-gamma.IL-12p40/IL-6 expression (p=0.009) and the diameter of residual lesion (p=0.011) remained significantly associated with survival, whereas high TNF-alpha expression lost significance. In conclusion, Th1 and Th2 cytokines might play an important role in regulating the immune reaction in epithelial ovarian cancer cells. IFN-gamma.IL-12p40/IL-6 expression may be a useful prognostic molecular marker for patients with advanced ovarian cancer.

摘要

本研究的目的是检测Th1(肿瘤坏死因子-α、干扰素-γ和白细胞介素-12p40)和Th2(白细胞介素-6和白细胞介素-10)细胞因子的mRNA表达水平,以探讨其与上皮性卵巢癌临床病理特征之间的关系。从40例上皮性卵巢癌样本中分离出mRNA,并制备cDNA。采用实时PCR技术(以甘油醛-3-磷酸脱氢酶基因作为内对照)检测各细胞因子mRNA的表达水平。用表达率(目的基因/甘油醛-3-磷酸脱氢酶)评估基因表达。将结果与临床分期、组织学分级和组织学类型进行分析。评估Th1/Th2值各组合的表达水平的预后意义。浆液性腺癌中肿瘤坏死因子-α(TNF-α)和干扰素-γ(IFN-γ)的表达水平显著高于非浆液性腺癌(p<0.05),但各细胞因子mRNA表达水平与临床分期或组织学分级之间无差异。对数秩检验显示,在晚期(II/III/IV期)卵巢癌中,高TNF-α mRNA表达(p=0.033)和初次手术时最大残留病灶直径(p=0.012)与较长生存期显著相关。在检测Th1/Th2表达值的所有组合时,最显著的关联是晚期(II/III/IV期)卵巢癌中高IFN-γ·IL-12p40/IL-6表达水平与较好预后之间的关联(p=0.004)。多因素分析显示,高IFN-γ·IL-12p40/IL-6表达(p=0.009)和残留病灶直径(p=0.011)仍与生存期显著相关,而高TNF-α表达则失去显著性。总之,Th1和Th2细胞因子可能在上皮性卵巢癌细胞免疫反应调节中起重要作用。IFN-γ·IL-12p40/IL-6表达可能是晚期卵巢癌患者有用的预后分子标志物。

相似文献

1
Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.Th1和Th2细胞因子mRNA的相对表达水平是卵巢癌患者独立的预后因素。
Oncol Rep. 2005 Jun;13(6):1153-8.
2
Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.Th1/Th2相关转录因子的基因表达升高与系统性红斑狼疮患者的疾病活动相关。
J Rheumatol. 2007 Jan;34(1):89-96. Epub 2006 Nov 15.
3
Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.人激肽释放酶8(hK8/TADG-14)的表达与卵巢癌的早期临床分期及良好预后相关。
Oncol Rep. 2004 Jun;11(6):1153-9.
4
Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease.丙型肝炎病毒感染中细胞因子mRNA的表达:慢性丙型肝炎患者以TH1为主,自限性疾病患者呈现TH1-TH2细胞因子谱。
J Viral Hepat. 2008 Feb;15(2):145-54. doi: 10.1111/j.1365-2893.2007.00908.x.
5
Impact of plastic adhesion in vitro on analysis of Th1 and Th2 cytokines and immune cell distribution from mice with multiple low-dose streptozotocin-induced diabetes.体外塑料黏附对多次低剂量链脲佐菌素诱导的糖尿病小鼠Th1和Th2细胞因子分析及免疫细胞分布的影响
J Immunol Methods. 2005 Dec 20;307(1-2):73-81. doi: 10.1016/j.jim.2005.09.008. Epub 2005 Oct 17.
6
Th1/Th2 type cytokines in hepatitis B patients treated with interferon-alpha.接受α干扰素治疗的乙肝患者体内的Th1/Th2型细胞因子
Chin Med J (Engl). 2001 Sep;114(9):921-4.
7
Shift in Th1 (IL-2 and IFN-gamma) and Th2 (IL-10 and IL-4) cytokine mRNA balance within two new histological main-types of rheumatoid-arthritis (RA).类风湿性关节炎(RA)两种新的组织学主要类型中Th1(白细胞介素-2和干扰素-γ)和Th2(白细胞介素-10和白细胞介素-4)细胞因子mRNA平衡的变化
Cell Mol Biol (Noisy-le-grand). 2002 May;48(3):285-93.
8
[The imbalance of Th1/Th2 cytokine expression in peripheral blood mononuclear cell from asthmatic patients and the effect of erythromycin on these cytokines].[哮喘患者外周血单个核细胞中Th1/Th2细胞因子表达失衡及红霉素对这些细胞因子的影响]
Zhonghua Jie He He Hu Xi Za Zhi. 2000 Jun;23(6):347-50.
9
[Profiles of type 1 and type 2 T cells in chronic idiopathic thrombocytopenic purpura].[慢性特发性血小板减少性紫癜中1型和2型T细胞的特征]
Zhonghua Yi Xue Za Zhi. 2006 Mar 14;86(10):669-73.
10
Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.使用以迟发型超敏反应(DTH)为导向剂量的链球菌制剂OK-432对胃癌恶性腹水进行局部区域免疫治疗:治疗腹水中的Th1功能障碍。
Int J Oncol. 2004 Apr;24(4):959-66.

引用本文的文献

1
Pan-cancer analysis reveals ASCC family promotes the cancer progression of lung adenocarcinoma.泛癌分析显示ASCC家族促进肺腺癌的癌症进展。
Sci Rep. 2025 Jul 2;15(1):22799. doi: 10.1038/s41598-025-03946-0.
2
From Defense to Disease: How the Immune System Fuels Epithelial-Mesenchymal Transition in Ovarian Cancer.从防御到疾病:免疫系统如何助力卵巢癌中的上皮-间质转化
Int J Mol Sci. 2025 Apr 24;26(9):4041. doi: 10.3390/ijms26094041.
3
Development of a prognostic model based on lysosome-related genes for ovarian cancer: insights into tumor microenvironment, mutation patterns, and personalized treatment strategies.
基于溶酶体相关基因的卵巢癌预后模型的开发:对肿瘤微环境、突变模式和个性化治疗策略的见解
Cancer Cell Int. 2024 Dec 19;24(1):419. doi: 10.1186/s12935-024-03586-w.
4
Tumor-Infiltrating Immune Cells in Colorectal Cancer.结直肠癌中的肿瘤浸润免疫细胞
Neoplasia. 2025 Jan;59:101091. doi: 10.1016/j.neo.2024.101091. Epub 2024 Dec 5.
5
Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies?Th17细胞在癌症中的作用:免疫抑制剂还是抗肿瘤盟友?
Cancer Cell Int. 2024 Oct 27;24(1):355. doi: 10.1186/s12935-024-03525-9.
6
Tumor immunity: A brief overview of tumor‑infiltrating immune cells and research advances into tumor‑infiltrating lymphocytes in gynecological malignancies (Review).肿瘤免疫:肿瘤浸润免疫细胞概述及妇科恶性肿瘤中肿瘤浸润淋巴细胞的研究进展(综述)
Exp Ther Med. 2024 Feb 26;27(4):166. doi: 10.3892/etm.2024.12453. eCollection 2024 Apr.
7
System analysis based on the T cell exhaustion‑related genes identifies CD38 as a novel therapy target for ovarian cancer.基于 T 细胞耗竭相关基因的系统分析鉴定 CD38 为卵巢癌的一个新的治疗靶点。
Oncol Res. 2023 Jun 27;31(4):591-604. doi: 10.32604/or.2023.029282. eCollection 2023.
8
T cells in health and disease.健康与疾病中的 T 细胞。
Signal Transduct Target Ther. 2023 Jun 19;8(1):235. doi: 10.1038/s41392-023-01471-y.
9
Role and Potential of Different T Helper Cell Subsets in Adoptive Cell Therapy.不同辅助性T细胞亚群在过继性细胞治疗中的作用与潜力
Cancers (Basel). 2023 Mar 8;15(6):1650. doi: 10.3390/cancers15061650.
10
NFE2L3 as a Novel Biomarker Associated With IL-2/STAT5/NLRP3 Signaling Pathway in Malignant Pleural Mesothelioma and Other Cancers.NFE2L3作为一种与恶性胸膜间皮瘤及其他癌症中IL-2/STAT5/NLRP3信号通路相关的新型生物标志物。
Front Genet. 2022 May 18;13:805256. doi: 10.3389/fgene.2022.805256. eCollection 2022.